NeuroPace (NPCE) Capital Expenditures (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Capital Expenditures of $114000.0 in Q1 2026, up 850.0% quarter-over-quarter from $12000.0 in Q4 2025, and up 208.11% on a YoY basis from $37000.0 in Q1 2025.
NeuroPace (NPCE) Capital Expenditures (2020 - 2026) Analysis & Trends
NeuroPace's Capital Expenditures history runs 7 years deep, the most recent figure standing at $114000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 208.11% year-over-year to $114000.0; the TTM figure through Mar 2026 stood at $90000.0 (up 8900.0% YoY), while the FY2025 annual figure was $13000.0, down 31.58% from the prior year.
- Capital Expenditures was $114000.0 for Q1 2026 at NeuroPace, up from $12000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $470000.0 in Q3 2022 to a low of -$377000.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $24214.3 across 5 years, with a median of $15500.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 344.81% in 2022, then jumped 325.81% in 2023.
- A 5-year view of Capital Expenditures shows it stood at -$377000.0 in 2022, then surged by 80.9% to -$72000.0 in 2023, then jumped by 126.39% to $19000.0 in 2024, then slumped by 36.84% to $12000.0 in 2025, then surged by 850.0% to $114000.0 in 2026.
- The last three Capital Expenditures figures came in at $114000.0 (Q1 2026), $12000.0 (Q4 2025), and -$24000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | 114,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114,000.00 |
| Mar 31, 2026 | 114,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Jun 30, 2024 | -55,000.00 |
| Jun 30, 2024 | -55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |